Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
- Address
- Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
Neoplasms and Cardiovascular Diseases
At Erasmus Universitair Medisch Centrum Rotterdam, clinical research spans both cancer and heart disease, with studies focused on improving treatment outcomes and supporting better disease control. The work includes trials in medical oncology as well as cardiology, reflecting a broad interest in advancing care for serious conditions.
- Research in muscle invasive bladder cancer is evaluating whether adding a new therapy to standard chemoradiotherapy can improve disease control and event-free survival.
- Studies in diffuse large B-cell lymphoma are exploring treatment strategies for aggressive blood cancers, with the goal of strengthening response and reducing the risk of relapse.
- A heart failure trial is assessing the safety and tolerability of a new cardiovascular treatment approach for patients living with chronic cardiac disease.
Across these trials, the main emphasis is on testing new therapies and improving how well current treatments work for patients with difficult-to-treat malignancies and cardiovascular conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 30 therapeutic areas and 15 of 839 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 775 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 135 by active trials.
lock +134 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +85 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
lock Showing 1 of 711 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors | Cogent Biosciences Inc. | Phase III | Not Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 839 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 43 | Unknown | 2016-03-15 | 2026-07-14 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.